Vaccine hopes and concerns

The approval of COVID-19 vaccines in India this week were quicker than most had expected, but concerns over the approval process and pricing disagreements underscore some of the challenges that remain to widespread vaccination. On balance, we continue to assume that India’s most vulnerable will be largely vaccinated by Q2 2022. That would probably allow a rolling back of restrictions on most domestic activity during the second half of this year.